chr17-39408775-G-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_004774.4(MED1):c.3446C>A(p.Ser1149Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.00000684 in 1,461,782 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 31)
Exomes 𝑓: 0.0000068 ( 0 hom. )
Consequence
MED1
NM_004774.4 missense
NM_004774.4 missense
Scores
6
13
Clinical Significance
Conservation
PhyloP100: 6.61
Genes affected
MED1 (HGNC:9234): (mediator complex subunit 1) The activation of gene transcription is a multistep process that is triggered by factors that recognize transcriptional enhancer sites in DNA. These factors work with co-activators to direct transcriptional initiation by the RNA polymerase II apparatus. The protein encoded by this gene is a subunit of the CRSP (cofactor required for SP1 activation) complex, which, along with TFIID, is required for efficient activation by SP1. This protein is also a component of other multisubunit complexes e.g. thyroid hormone receptor-(TR-) associated proteins which interact with TR and facilitate TR function on DNA templates in conjunction with initiation factors and cofactors. It also regulates p53-dependent apoptosis and it is essential for adipogenesis. This protein is known to have the ability to self-oligomerize. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.27739227).
BS2
High AC in GnomAdExome4 at 10 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MED1 | NM_004774.4 | c.3446C>A | p.Ser1149Tyr | missense_variant | 17/17 | ENST00000300651.11 | NP_004765.2 | |
MED1 | XM_047436314.1 | c.2930C>A | p.Ser977Tyr | missense_variant | 13/13 | XP_047292270.1 | ||
MED1 | XM_047436315.1 | c.2789C>A | p.Ser930Tyr | missense_variant | 9/9 | XP_047292271.1 | ||
MED1 | XM_006721957.3 | c.1640+1806C>A | intron_variant | XP_006722020.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MED1 | ENST00000300651.11 | c.3446C>A | p.Ser1149Tyr | missense_variant | 17/17 | 1 | NM_004774.4 | ENSP00000300651.6 | ||
MED1 | ENST00000394287.7 | c.1640+1806C>A | intron_variant | 1 | ENSP00000377828.3 | |||||
MED1 | ENST00000577831.5 | n.*3019C>A | non_coding_transcript_exon_variant | 16/16 | 2 | ENSP00000463307.1 | ||||
MED1 | ENST00000577831.5 | n.*3019C>A | 3_prime_UTR_variant | 16/16 | 2 | ENSP00000463307.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251014Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135708
GnomAD3 exomes
AF:
AC:
1
AN:
251014
Hom.:
AF XY:
AC XY:
0
AN XY:
135708
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461782Hom.: 0 Cov.: 35 AF XY: 0.00000550 AC XY: 4AN XY: 727176
GnomAD4 exome
AF:
AC:
10
AN:
1461782
Hom.:
Cov.:
35
AF XY:
AC XY:
4
AN XY:
727176
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 27, 2023 | The c.3446C>A (p.S1149Y) alteration is located in exon 17 (coding exon 17) of the MED1 gene. This alteration results from a C to A substitution at nucleotide position 3446, causing the serine (S) at amino acid position 1149 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Benign
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MutPred
Gain of catalytic residue at S1149 (P = 0.0044);
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at